NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

53 hedge funds and large institutions have $3.91M invested in Navidea Biopharmaceuticals Inc. in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
-1
Holders Change %
-1.85%
% of All Funds
1.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
7
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CWM
1
Cornerstone Wealth Management
Missouri
$1.13M
2
VF
2
Virtu Financial
New York
$25K
3
CWM
3
Cabot Wealth Management
Massachusetts
$14K
4
Jane Street
4
Jane Street
New York
$11K
5
SFS
5
Sowell Financial Services
Arkansas
$55K

Top Sellers

1
Jacobs Levy Equity Management
1
Jacobs Levy Equity Management
New Jersey
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$31K
3
PP
3
PDS Planning
Ohio
$0
4
Ameriprise
4
Ameriprise
Minnesota
$0
5
State Street
5
State Street
Massachusetts
$15K
Name Holding Trade Value Shares
Change 		Shares
Change %
PP
51
PDS Planning
Ohio
– -$8K -1,798 Closed
Ameriprise
52
Ameriprise
Minnesota
– -$3K -680 Closed
1 2
3